322 related articles for article (PubMed ID: 15760766)
1. Gene dosage and pathogenesis of Parkinson's disease.
Eriksen JL; Przedborski S; Petrucelli L
Trends Mol Med; 2005 Mar; 11(3):91-6. PubMed ID: 15760766
[TBL] [Abstract][Full Text] [Related]
2. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
[TBL] [Abstract][Full Text] [Related]
4. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
[TBL] [Abstract][Full Text] [Related]
5. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
[TBL] [Abstract][Full Text] [Related]
6. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease.
Sidhu A; Wersinger C; Vernier P
FEBS Lett; 2004 May; 565(1-3):1-5. PubMed ID: 15135042
[TBL] [Abstract][Full Text] [Related]
7. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease.
Gispert S; Trenkwalder C; Mota-Vieira L; Kostic V; Auburger G
Arch Neurol; 2005 Jan; 62(1):96-8. PubMed ID: 15642855
[TBL] [Abstract][Full Text] [Related]
8. Wild-type and mutant alpha-synuclein induce a multi-component gene expression profile consistent with shared pathophysiology in different transgenic mouse models of PD.
Miller RM; Kiser GL; Kaysser-Kranich T; Casaceli C; Colla E; Lee MK; Palaniappan C; Federoff HJ
Exp Neurol; 2007 Mar; 204(1):421-32. PubMed ID: 17254569
[TBL] [Abstract][Full Text] [Related]
9. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice.
Plaas M; Karis A; Innos J; Rebane E; Baekelandt V; Vaarmann A; Luuk H; Vasar E; Koks S
J Physiol Pharmacol; 2008 Jun; 59(2):205-16. PubMed ID: 18622040
[TBL] [Abstract][Full Text] [Related]
11. Alpha-synuclein mRNA expression in sporadic Parkinson's disease.
Tan EK; Chandran VR; Fook-Chong S; Shen H; Yew K; Teoh ML; Yuen Y; Zhao Y
Mov Disord; 2005 May; 20(5):620-3. PubMed ID: 15719423
[TBL] [Abstract][Full Text] [Related]
12. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
[TBL] [Abstract][Full Text] [Related]
13. Low frequency of alpha-synuclein mutations in familial Parkinson's disease.
Farrer M; Wavrant-De Vrieze F; Crook R; Boles L; Perez-Tur J; Hardy J; Johnson WG; Steele J; Maraganore D; Gwinn K; Lynch T
Ann Neurol; 1998 Mar; 43(3):394-7. PubMed ID: 9506559
[TBL] [Abstract][Full Text] [Related]
14. Nosology of Parkinson's disease: looking for the way out of a quagmire.
Forman MS; Lee VM; Trojanowski JQ
Neuron; 2005 Aug; 47(4):479-82. PubMed ID: 16102530
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease.
Hope AD; Myhre R; Kachergus J; Lincoln S; Bisceglio G; Hulihan M; Farrer MJ
Neurosci Lett; 2004 Aug; 367(1):97-100. PubMed ID: 15308306
[TBL] [Abstract][Full Text] [Related]
16. alpha-Synuclein locus triplication causes Parkinson's disease.
Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
[No Abstract] [Full Text] [Related]
17. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
Krüger R; Kuhn W; Müller T; Woitalla D; Graeber M; Kösel S; Przuntek H; Epplen JT; Schöls L; Riess O
Nat Genet; 1998 Feb; 18(2):106-8. PubMed ID: 9462735
[No Abstract] [Full Text] [Related]
18. The role of alpha-synuclein in Parkinson's disease: insights from animal models.
Maries E; Dass B; Collier TJ; Kordower JH; Steece-Collier K
Nat Rev Neurosci; 2003 Sep; 4(9):727-38. PubMed ID: 12951565
[No Abstract] [Full Text] [Related]
19. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
[TBL] [Abstract][Full Text] [Related]
20. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
